← Back to Search

Dietary Supplement

Dietary Fiber (Inulin) for Gut Health and Immune Response

Phase < 1
Recruiting
Led By Mary Kable, PhD
Research Sponsored by USDA, Western Human Nutrition Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males 18 - 30 years old, less than 34 g/day
Females 31 - 50 years old, less than 25 g/day
Timeline
Screening 3 weeks
Treatment Varies
Follow Up period 1: days 1-7; period 2: days 16-25; period 3: days 26-36; period 4: days 37-43; period 5: days 58-65
Awards & highlights

Study Summary

This trial will test whether adding dietary fiber, in the form of inulin, to a diet lacking in fiber will raise levels of potentially beneficial gut bacteria, such as Bifidobacterium. The investigators will examine how inulin affects gut health and immune response, including to vaccines.

Who is the study for?
This trial is for healthy men and women aged 18-50 with a BMI of 18.5-30.9 who don't eat enough fiber, defined as less than daily recommended amounts based on age and gender. Participants should not have used certain medications recently, including antibiotics or anti-malaria drugs, have no history of typhoid fever or GI surgery, are not pregnant or lactating, do not have chronic illnesses like diabetes or heart disease, and are willing to avoid some supplements during the study.Check my eligibility
What is being tested?
The study tests if adding inulin (a type of dietary fiber) instead of maltodextrin (control) to participants' diets can improve gut health by increasing beneficial bacteria levels and enhancing immune response to the Ty21a typhoid vaccine. It will measure changes in gut microbes, inflammation reduction, vaccine response enhancement, and white blood cell adhesion molecule expression.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort such as bloating or gas due to increased fiber intake with inulin. The Ty21a typhoid vaccine could cause mild reactions like soreness at the injection site or low-grade fever.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a male between 18 and 30 years old.
Select...
I am a woman aged 31-50 and drink less than 25g of alcohol daily.
Select...
I am a man aged 31-50 and consume less than 31 grams of alcohol daily.
Select...
I am a woman aged 18-30 and drink less than 28 grams of alcohol daily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~period 1: days 1-7; period 2: days 16-25; period 3: days 26-36; period 4: days 37-43; period 5: days 58-65
This trial's timeline: 3 weeks for screening, Varies for treatment, and period 1: days 1-7; period 2: days 16-25; period 3: days 26-36; period 4: days 37-43; period 5: days 58-65 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Typhoid Fever
Secondary outcome measures
Change in GI symptoms
Body Weight Changes
Change in blood monocyte subsets
+14 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Inulin and Ty21a VaccineExperimental Treatment2 Interventions
Participants will consume 12 grams/day of inulin for 3 weeks before the administration of the Ty21a vaccine, 1 week during the vaccine, and 1 week after the vaccine for a total of 5 weeks.
Group II: Maltodextrin and Ty21a VaccinePlacebo Group2 Interventions
Participants will consume 12 grams/day of maltodextrin (control) for 3 weeks before the administration of the Ty21a vaccine, 1 week during the vaccine, and 1 week after the vaccine for a total of 5 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Inulin
2011
Completed Phase 4
~780

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER
1,380 Previous Clinical Trials
1,588,685 Total Patients Enrolled
17 Trials studying Inflammation
1,238 Patients Enrolled for Inflammation
USDA, Western Human Nutrition Research CenterLead Sponsor
62 Previous Clinical Trials
21,047 Total Patients Enrolled
7 Trials studying Inflammation
582 Patients Enrolled for Inflammation
Mary Kable, PhDPrincipal InvestigatorUSDA, ARS, Western Human Nutrition Research Center
1 Previous Clinical Trials
80 Total Patients Enrolled

Media Library

Inulin (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04543877 — Phase < 1
Inflammation Research Study Groups: Inulin and Ty21a Vaccine, Maltodextrin and Ty21a Vaccine
Inflammation Clinical Trial 2023: Inulin Highlights & Side Effects. Trial Name: NCT04543877 — Phase < 1
Inulin (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04543877 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is octogenarian age a permissible criterion for enrollment in this research study?

"In accordance with the requirements for enrollment, individuals must be between 18 and 50 years of age to qualify."

Answered by AI

Are there any eligibility requirements for participation in this research trial?

"This research effort is seeking 60 individuals aged 18-50 with inflammation to participate. To be considered, applicants must satisfy the following parameters: Body Mass Index (BMI) of 18.5 - 30.9 kg/m2; females between ages 18 and 30 should consume no greater than 28 g/day while males in this age bracket cannot exceed 34 g/day; finally, for male and female participants over 31 years old, a maximum daily intake of 25g and 31g respectively is prescribed."

Answered by AI

Are there any antecedent studies regarding the use of Inulin?

"Currently, there are 4 ongoing trials of Inulin in development, with none reaching Phase 3. Most trails for this medicine are located near Baltimore, Maryland but other centres across the USA have studies underway as well."

Answered by AI

How many participants have been accepted into this research project?

"Affirmative. Clinicaltrial.gov data points to the fact that this trial is currently seeking participants, with an initial posting on September 27th 2022 and a final update being made November 29th of the same year. 60 people need to be enrolled at one location for successful completion."

Answered by AI

Are there any available patient slots for this clinical research project?

"Data on clinicaltrials.gov indicates that this trial is presently recruiting potential participants, which first appeared on September 27th 2022 and was last revised November 29th 2022."

Answered by AI

What results are researchers expecting from this clinical research?

"This clinical trial seeks to identify a change in antibody response to typhoid vaccination within Days 26, 37 and 39. Secondary objectives include assessing dietary fibre intake with a food frequency questionnaire, measuring acute phase reactants C-reactive protein (CRP) and serum amyloid A (SAA), as well as determining the relative abundance of colonic bacteria via polymerase chain reaction amplification and sequencing of 16s ribosomal RNA from stool samples collected 3 times per period."

Answered by AI
Recent research and studies
~12 spots leftby Sep 2024